Skip to main content
. 2015 Aug 17;6(30):30165–30177. doi: 10.18632/oncotarget.5030

Figure 6. RASSF8 expression and clinical role in melanoma.

Figure 6

A. The representative photographs of negative control and positive expression of RASSF8 in melanoma tumors. B. RASSF8 expression was lower in stage III/IV advanced melanomas than in stage I/II early melanomas. C. Overall survival (OS) was better when RASSF8 expression was high. D. Schematic model for regulation of P53-P21 pathway and P65 expression by RASSF8.